Amphasys was founded in 2012 as a spin-off from Axetris AG, a company of the Leister group. The company focuses its activities in developing and marketing a novel, chip-based single cell analysis technology. Amphasys' mission is to simplify, speed up and miniaturize complex cell analyses and move them to the point-of-use, which may be outside well-equipped research and analytical laboratories. The basic technology has been developed in 2004 in collaboration with the Swiss Federal Institute of Technology Lausanne (EPFL). Consequently, several years of research with different cell types proved that the technology is suitable for a wide array of applications. So far, two of the most promising fields turned out to be analysis of pollen and milk. In 2013 Amphasys was awarded with the most prestigious Swiss startup price by the W.A. de Vigier Foundation. Amphasys was also supported by the Albert Koechlin Foundation and certified by CTI Invest®. Today, Amphasys is a speedily growing high tech company dedicated to reinventing single cell analysis and applying it to industrial production processes.
- About us